• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:杨茹,徐颖,叶冠.抗衰老片治疗2型糖尿病能量代谢的网络药理学分析及实验验证[J].药学研究,2023,42(3):155-160,169[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2435次   下载 3021次 本文二维码信息
码上扫一扫!
抗衰老片治疗2型糖尿病能量代谢的网络药理学分析及实验验证
杨茹,徐颖,叶冠
字体:加大+|默认|缩小-
(上海医药集团中药研究所有限公司,上海 201203)
摘要:
目的 基于网络药理学和体内实验探究抗衰老片治疗2型糖尿病(type 2 diabetes mellitus,T2DM)能量代谢的作用机制。方法 通过TCMSP筛选抗衰老片中药材的主要化学成分及其靶点,并通过文献调研、Pubchem对抗衰老片中药材的主要成分进行补充,经SwissTargetPrediction数据库预测靶点;通过GeneCards、OMIM数据库获取T2DM、能量代谢相关靶点;通过Venny 2.1.0平台获得抗衰老片与T2DM、能量代谢的共同靶点;基于STRING数据库和Cytoscape 3.8.0软件构建药物与疾病共同靶点的蛋白互作网络图;基于R语言进行GO和KEGG富集分析;通过ELISA、Western Blot法验证抗衰老片对T2DM大鼠能量代谢的作用。结果 筛选出抗衰老片223个活性成分和1 232个靶点,T2DM靶点10 871个,能量代谢相关靶点9013个;抗衰老片、T2DM和能量代谢的共同靶点625个。关键靶点在KEGG富集分析主要涉及MAPK、PI3K/Akt、JAK/STAT等信号通路。实验结果表明,与模型组相比,抗衰老片能显著降低T2DM大鼠血糖水平,改善能量代谢相关指标含量,显著上调PI3K/Akt蛋白的磷酸化水平(P<0.05)。结论 抗衰老片可调节T2DM能量代谢,其作用机制可能与PI3K/Akt信号通路相关。
关键词:  抗衰老片  2型糖尿病  能量代谢  网络药理学  实验验证
DOI:10.13506/j.cnki.jpr.2023.03.003
基金项目:上海市科委专项“上海医药战略大品种二次开发”(No.15DZ1900100)
Network pharmacological analysis and experimental validation of Arti-aging Tablets in the treatment of energy metabolism in type 2 diabetes mellitus
YANG Ru,XU Ying,YE Guan
(Institute of Traditional Chinese Medicine, Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 201203,China)
Abstract:
Objective To explore the mechanism of Arti-aging Tablets (KSLP) in the treatment of energy metabolism disorders in type 2 diabetes mellitus (T2DM) based on network pharmacology and in vivo experiments.Methods The major components and their targets of traditional Chinese medicines (TCM) in KSLP were screened by TCMSP, and the main components of TCM in KSLP were supplemented by literature and Pubchem, and the targets of supplemented components were predicted by the SwissTargetPrediction. T2DM and energy metabolism related targets were obtained from the database of GeneCards and OMIM. Common targets of KSLP, T2DM and energy metabolism were focused by intersection. The protein-protein interaction (PPI) network of the common targets of drugs and diseases was constructed based on the STRING and Cytoscape 3.8.0. R language was used for GO and KEGG enrichment analysis. Finally, ELISA and Western Blot were performed to demonstrate the effects of KSLP on energy metabolism disorder in T2DM rats. Results There were 223 active ingredients, 1 232 predicted targets in KSLP, 10 871 targets in T2DM, 9013 targets in energy metabolism, and 625 common targets of KSLP, T2DM and energy metabolism. The key targets in KEGG enrichment analysis mainly involved MAPK, PI3K/Akt, JAK/STAT signaling pathways, etc. The experimental results showed that KSLP markedly reduced the T2DM-induced elevated blood glucose level, improved the contents of energy metabolism-related indicators, and upregulated the phosphorylation levels of PI3K and Akt in T2DM rats (P<0.05).Conclusion KSLP could improve the energy metabolism in T2DM, and its underlying mechanism might be related to the PI3K/Akt pathway.
Key words:  Arti-aging Tablets  Type 2 diabetes mellitus  Energy metabolism  Network pharmacology  Experimental verification
今日访问量:2327    总访问量:55338694
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司